Interleukin-6 (IL-6), a pro-inflammatory cytokine, has also been widely studied for its role in MS, with elevated IL-6 levels generally correlating with increased disease activity and clinical deterioration [8,9]. The gene discussed is IL6; the disease is myeloid sarcoma.